Compounds > cytarabine

cytarabine and amidox

cytarabine has been researched along with amidox in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauer, W; Elford, HL; Fritzer-Szekeres, M; Höchtl, T; Horvath, Z; Karl, D; Saiko, P; Szekeres, T1
Bauer, W; Fritzer-Szekeres, M; Höchtl, T; Horvath, Z; Karl, D; Saiko, P; Szekeres, T1

Other Studies

2 other study(ies) available for cytarabine and amidox

ArticleYear
Biochemical modulation of Ara-C effects by amidox, an inhibitor of ribonucleotide reductase in HL-60 promyelocytic human leukemia cells.
    Life sciences, 2004, Jan-16, Volume: 74, Issue:9

    Topics: Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Cell Division; Colony-Forming Units Assay; Cytarabine; Deoxyribonucleotides; Growth Inhibitors; HL-60 Cells; Humans; Oximes; Ribonucleotide Reductases

2004
Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells.
    Nucleosides, nucleotides & nucleic acids, 2004, Volume: 23, Issue:8-9

    Topics: Agar; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Cytarabine; Deoxycytosine Nucleotides; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; Inhibitory Concentration 50; Oximes; Ribonucleotide Reductases; Time Factors

2004